Skip to main content

MYLAN 2302 MYLAN 2302 Pill - brown beige capsule/oblong, 18mm

Pill with imprint MYLAN 2302 MYLAN 2302 is Brown / Beige, Capsule/Oblong and has been identified as Prazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc.

Prazosin is used in the treatment of Benign Prostatic Hyperplasia; Heart Failure; High Blood Pressure; Raynaud's Syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Prazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2302 MYLAN 2302

Prazosin hydrochloride 2 mg MYLAN 2302 MYLAN 2302
Prazosin hydrochloride 2 mg MYLAN 2302 MYLAN 2302
Prazosin hydrochloride 2 mg MYLAN 2302 MYLAN 2302
Prazosin hydrochloride 2 mg MYLAN 2302 MYLAN 2302 Front
Prazosin hydrochloride 2 mg MYLAN 2302 MYLAN 2302 Back

Prazosin Hydrochloride

Imprint
MYLAN 2302 MYLAN 2302
Strength
2 mg
Color
Brown / Beige
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferrosoferric oxide, gelatin, ferric oxide red, titanium dioxide, ferric oxide yellow, D&C Red No. 28, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, ammonia, propylene glycol, shellac, dimethicone

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2302 Mylan Pharmaceuticals Inc.
51079-0631 UDL Laboratories Inc.
54569-2583 A-S Medication Solutions, LLC (repackager)
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer